3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Urinary Bladder Neoplasms
157
Carcinoma, Transitional Cell
56
Non-Muscle Invasive Bladder Neoplasms
30
Urethral Neoplasms
24
Carcinoma, Renal Cell
23
Neoplasms
19
Kidney Neoplasms
15
Pancreatic Neoplasms
14
Ovarian Neoplasms
14
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
13
Prostatic Neoplasms
12
Ureteral Neoplasms
11
Urologic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Lung Neoplasms
7
Testicular Neoplasms
6
Stomach Neoplasms
6
Melanoma
6
Sarcoma
5
Urothelial Cancer
4
Squamous Cell Carcinoma of Head and Neck
4
Small Cell Lung Carcinoma
4
Osteosarcoma
4
Colonic Neoplasms
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Interventions
Cisplatin
11
Paclitaxel
9
Ifosfamide
9
Filgrastim
8
Etoposide
8
Bleomycin
7
Carboplatin
5
pegfilgrastim
3
Peripheral Blood Stem Cell Transplantation
3
liposomal amphotericin B
2
Therapeutics
2
Radiotherapy
2
Granulocyte Colony-Stimulating Factor
2
Cyclophosphamide
2
sargramostim
1
sabarubicin
1
ixabepilone
1
etoposide phosphate
1
aldesleukin
1
Vincristine
1
Vinblastine
1
Thiotepa
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Ribavirin
1
Psychiatric Rehabilitation
1
Palivizumab
1
Oxaliplatin
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endodermal Sinus Tumor
×
Gemcitabine
×
Genitourinary
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled